BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30269599)

  • 1. Small animal models of filovirus disease: recent advances and future directions.
    Cross RW; Fenton KA; Geisbert TW
    Expert Opin Drug Discov; 2018 Nov; 13(11):1027-1040. PubMed ID: 30269599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small Animal Models for Evaluating Filovirus Countermeasures.
    Banadyga L; Wong G; Qiu X
    ACS Infect Dis; 2018 May; 4(5):673-685. PubMed ID: 29457711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal models for filovirus infections.
    Siragam V; Wong G; Qiu XG
    Zool Res; 2018 Jan; 39(1):15-24. PubMed ID: 29511141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferrets Infected with Bundibugyo Virus or Ebola Virus Recapitulate Important Aspects of Human Filovirus Disease.
    Kozak R; He S; Kroeker A; de La Vega MA; Audet J; Wong G; Urfano C; Antonation K; Embury-Hyatt C; Kobinger GP; Qiu X
    J Virol; 2016 Oct; 90(20):9209-23. PubMed ID: 27489269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rodent-Adapted Filoviruses and the Molecular Basis of Pathogenesis.
    Banadyga L; Dolan MA; Ebihara H
    J Mol Biol; 2016 Aug; 428(17):3449-66. PubMed ID: 27189922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ferret as a Model for Filovirus Pathogenesis and Countermeasure Evaluation.
    Schiffman Z; Liu G; Cao W; Zhu W; Emeterio K; Qiu X; Banadyga L
    ILAR J; 2022 Jan; 61(1):62-71. PubMed ID: 33951727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus.
    Cross RW; Mire CE; Borisevich V; Geisbert JB; Fenton KA; Geisbert TW
    J Infect Dis; 2016 Aug; 214(4):565-9. PubMed ID: 27354371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small Animal Models for Studying Filovirus Pathogenesis.
    Yamaoka S; Banadyga L; Bray M; Ebihara H
    Curr Top Microbiol Immunol; 2017; 411():195-227. PubMed ID: 28653189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Reston virus infection in ferrets.
    Yan F; He S; Banadyga L; Zhu W; Zhang H; Rahim MN; Collignon B; Senthilkumaran C; Embury-Hyatt C; Qiu X
    Antiviral Res; 2019 May; 165():1-10. PubMed ID: 30836107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Filovirus-like particles as vaccines and discovery tools.
    Warfield KL; Swenson DL; Demmin G; Bavari S
    Expert Rev Vaccines; 2005 Jun; 4(3):429-40. PubMed ID: 16026254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models for ebolavirus countermeasures discovery: what defines a useful model?
    Shurtleff AC; Bavari S
    Expert Opin Drug Discov; 2015 Jul; 10(7):685-702. PubMed ID: 26004783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Single-Vector, Single-Injection Trivalent Filovirus Vaccine: Proof of Concept Study in Outbred Guinea Pigs.
    Mire CE; Geisbert JB; Versteeg KM; Mamaeva N; Agans KN; Geisbert TW; Connor JH
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S384-8. PubMed ID: 25957964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.
    Keck ZY; Enterlein SG; Howell KA; Vu H; Shulenin S; Warfield KL; Froude JW; Araghi N; Douglas R; Biggins J; Lear-Rooney CM; Wirchnianski AS; Lau P; Wang Y; Herbert AS; Dye JM; Glass PJ; Holtsberg FW; Foung SK; Aman MJ
    J Virol; 2016 Jan; 90(1):279-91. PubMed ID: 26468532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against filovirus infection: virus-like particle vaccines.
    Yang C; Ye L; Compans RW
    Expert Rev Vaccines; 2008 Apr; 7(3):333-44. PubMed ID: 18393603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Filoviruses].
    Takada A
    Uirusu; 2012; 62(2):197-208. PubMed ID: 24153230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses.
    Holtsberg FW; Shulenin S; Vu H; Howell KA; Patel SJ; Gunn B; Karim M; Lai JR; Frei JC; Nyakatura EK; Zeitlin L; Douglas R; Fusco ML; Froude JW; Saphire EO; Herbert AS; Wirchnianski AS; Lear-Rooney CM; Alter G; Dye JM; Glass PJ; Warfield KL; Aman MJ
    J Virol; 2016 Jan; 90(1):266-78. PubMed ID: 26468533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Sudan Ebolavirus infection in ferrets.
    Kroeker A; He S; de La Vega MA; Wong G; Embury-Hyatt C; Qiu X
    Oncotarget; 2017 Jul; 8(28):46262-46272. PubMed ID: 28545034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling the Disease Course of Zaire ebolavirus Infection in the Outbred Guinea Pig.
    Cross RW; Fenton KA; Geisbert JB; Mire CE; Geisbert TW
    J Infect Dis; 2015 Oct; 212 Suppl 2():S305-15. PubMed ID: 26038397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stat1-Deficient Mice Are Not an Appropriate Model for Efficacy Testing of Recombinant Vesicular Stomatitis Virus-Based Filovirus Vaccines.
    Marzi A; Kercher L; Marceau J; York A; Callsion J; Gardner DJ; Geisbert TW; Feldmann H
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S404-9. PubMed ID: 26022440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges, progress, and opportunities: proceedings of the filovirus medical countermeasures workshop.
    Hirschberg R; Ward LA; Kilgore N; Kurnat R; Schiltz H; Albrecht MT; Christopher GW; Nuzum E
    Viruses; 2014 Jul; 6(7):2673-97. PubMed ID: 25010768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.